List of works by Magne Børset

A method for measurement of drug sensitivity of myeloma cells co-cultured with bone marrow stromal cells

scientific article published on 27 February 2013

A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells

scientific article

Allelic mutations in noncoding genomic sequences construct novel transcription factor binding sites that promote gene overexpression

scientific article published on 29 July 2015

Apoptosis, proliferation and NF-kappaB activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor

scientific article

Apoptosis, proliferation and NF-κB activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor

scholarly article by Magne Børset et al published 24 April 2009 in European Journal of Haematology

Bone disease in multiple myeloma

scientific article published on January 2006

Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells

scientific article published on 01 January 2001

Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells

scientific article published on April 2004

Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC.

scientific article published on 23 September 2011

Comparison of the effects of 2-chlorodeoxyadenosine and melphalan myeloma cell lines

scientific article published on February 1996

Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines

scientific article published on October 1996

Correction: amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy

Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration

scientific article published on 7 July 2013

Elevated hepatocyte growth factor in sera from patients with insulin-dependent diabetes mellitus

scientific article published in July 1998

Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis

scientific article published on 01 January 2001

Elevated serum concentrations of activated hepatocyte growth factor activator in patients with multiple myeloma

scientific article published on 06 August 2008

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro

scientific article published on 31 August 2016

Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer

scientific article published on 30 November 2017

Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells

scientific article published on June 2000

FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14).

scientific article

HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase

scientific article published on 14 March 2013

HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma.

scientific article published on April 2007

Heparan sulfate regulates targeting of syndecan-1 to a functional domain on the cell surface

scientific article published on 3 February 2003

Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease.

scientific article

Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy

scientific article published on 01 December 2002

Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individuals

scientific article published in June 1999

Hepatocyte growth factor promotes migration of human myeloma cells

scientific article

Hepatocyte growth factor reverses the TGF-beta-induced growth inhibition of CCL-64 cells. A novel bioassay for HGF and implications for the TGF-beta bioassay

scientific article published on January 1996

High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis

scientific article published on 13 January 2009

High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity

scientific article (publication date: November 2000)

Human myeloma cells adhere to fibronectin in response to hepatocyte growth factor

scientific article

Identification of new targets for therapy of osteolytic bone disease in multiple myeloma.

scientific article

Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients

scientific article published on 9 April 2014

Immunisering i svangerskapet

scientific article published on 01 October 2009

Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease

scientific article published in February 2012

Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells

scientific article published on July 1999

Interleukin-21 is a growth and survival factor for human myeloma cells

scientific article published on May 2002

Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice

scientific article published on February 1999

Mn2+ regulates myeloma cell adhesion differently than the proadhesive cytokines HGF, IGF-1, and SDF-1alpha

scientific article published on 4 September 2008

OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus.

scientific article published on 23 April 2009

Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma

scientific article published on February 2004

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells

scientific article published on 01 October 2002

Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells

scientific article

PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patients

Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration

scientific article published on 15 March 2016

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration.

scientific article published on 10 April 2018

Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance

scientific article published on 13 December 2017

Preoperative traction in patients with hip fractures

scientific article published on 01 January 1992

Raised Serum Levels of Syndecan-1 (CD138), in a Case of Acute Idiopathic Systemic Capillary Leak Syndrome (SCLS) (Clarkson's Disease).

scientific article published on 16 February 2018

Role of hepatocyte growth factor and its receptor c-met in multiple myeloma

scientific article published on 01 September 1998

Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro

scientific article

Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma

scientific article published on 30 December 2010

Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor

scientific article published on 18 July 2002

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

scientific article published on 01 October 2001

Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.

scientific article published on 11 April 2011

Soluble c-Met in serum of patients with multiple myeloma: correlation with clinical parameters

scientific article published on 16 August 2011

Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3.

scientific article published on 03 October 2016

Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival

scientific article published on 01 January 2005

Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins.

scientific article published in October 2000

The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells

scientific article published on 27 March 2016

The role of hepatocyte growth factor and its receptor c-Met in multiple myeloma and other blood malignancies

scientific article

The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.

scientific article published on June 1996

Toll-like receptors mediate proliferation and survival of multiple myeloma cells

scientific article published on June 2006

VOLIN and KJON-Two novel hyperdiploid myeloma cell lines

scientific article published on 16 June 2016

c-Met signaling promotes IL-6-induced myeloma cell proliferation

scientific article

Paulina is supported by:

About Paulina

Help